Africa Western and Central vs Cambodia: Antiretroviral therapy coverage
Africa Western and Central
77.1%
in 2024
Cambodia
92.0%
in 2024
Africa Western and Central rank
15th
Cambodia rank
14th
Antiretroviral therapy coverage over time
- Africa Western and Central
- Cambodia
How they compare
Cambodia currently reports 92.0% against 77.1% in Africa Western and Central, a difference of 14.9%.
That makes Cambodia's figure about 1.2 times Africa Western and Central's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Cambodia ahead.
Africa Western and Central ranks 15th and Cambodia ranks 14th of 23 groups.
Cambodia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa Western and Central | Cambodia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.4% | 15.6% | 11.2% | Cambodia |
| 2010s | 33.6% | 64.6% | 31.0% | Cambodia |
| 2020s | 67.2% | 85.2% | 18.0% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Africa Western and Central or Cambodia?
- Cambodia, at 92.0% against 77.1% in Africa Western and Central as of 2024.
- What is the difference in antiretroviral therapy coverage between Africa Western and Central and Cambodia?
- 14.9%, with Cambodia ahead.
- How many years of comparable data are there for Africa Western and Central and Cambodia?
- 25 years are reported by both, from 2000 to 2024.
- How do Africa Western and Central and Cambodia rank globally for antiretroviral therapy coverage?
- Africa Western and Central ranks 15th and Cambodia ranks 14th of 23 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.